CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Biopharma Supply, Reimagined: Regional, Resilient Manufacturing

  Persistent disruption is redefining biopharma supply chains. Explore how regional manufacturing, integrated risk management, and closer collaboration help build resilience and improve agility.

• Maximizing Scale-Up Efficiency Of A mAb Upstream Process

  This study demonstrated the effectiveness of a medium and feed system when tested at three different scales for its ability to high-quality, fed-batch monoclonal antibodies.

• ICH E6(R3) In Effect: Transforming Quality Management For CGT Trials

  Discover how the updated ICH E6(R3) guideline supports the speed and complexity of CGT manufacturing, enabling flexible, risk‑based decisions and quality systems built to scale therapies safely.

• Manufacturing IPC/QC Of Gene-Engineered HSCs

  In-process and quality control ensure consistent manufacturing of gene-engineered hematopoietic stem cells. Discover an engineering process that enhances production through viral transduction and integrated sampling pouches.

• Cell Retention Technology And Specialized Cell Culture Media

  Explore how perfusion technology is transforming upstream bioprocessing by boosting productivity, reducing costs, and enabling process intensification while overcoming cell retention challenges.

• Perfusion Cell Line Development For Intensified Processes

  The biopharmaceutical industry is transforming by shifting to continuous and intensified upstream bioprocesses, which are driven by evolving demands. Discover the key goals and innovations shaping this transition for modern healthcare.

• How Can You Avoid Bioprocessing Risks When Using Cable Ties?

  Cable ties in bioprocessing can cause leaks, damage, and delays. See how switching to a uniform-sealing connector can significantly improve efficiency, reduce prep time, and minimize contamination risks.

• How To Unlock The Secret To Repeatable, Scalable Low Turnover

  Here, we explore the evolution of a 10-year partnership and extrapolate the principles that create cohesive teams and minimize turnover.

• Transforming Development Through Mass Spectrometry Data Analysis

  Mass spectrometry is vital for understanding PTMs in modern biologics. Explore key challenges and how streamlined analysis can reveal deeper, more sensitive insights into biotherapeutic structure.

• A Scalable Manufacturing Platform For The Purification Of Stem Cell Derived Exosomes

  EV production scale increases require paired robust, scalable, and cost-effective downstream processes. Process parameters can be tailored for therapeutic exosome programs and allow for maximum exosome recovery.